First Time Loading...
A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 26 000 KRW -1.52% Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
ABL Bio Inc

Wall Street analysts forecast ABL Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 36 210 KRW with a low forecast of 35 350 KRW and a high forecast of 37 800 KRW.

Lowest Forecast
Wall Street Target
35 350 KRW
36% Upside
Average Forecast
Wall Street Target
36 210 KRW
39% Upside
Highest Forecast
Wall Street Target
37 800 KRW
45% Upside
Lowest
Price Target
35 350 KRW
36% Upside
Average
Price Target
36 210 KRW
39% Upside
Highest
Price Target
37 800 KRW
45% Upside
ABL Bio Inc Competitors:
Price Targets
OCC
Orthocell Ltd
46% Upside
FYB
Formycon AG
160% Upside
CDNA
CareDx Inc
63% Upside
VYGR
Voyager Therapeutics Inc
132% Upside
OCC
Orthocell Ltd
46% Upside
FYB
Formycon AG
160% Upside
CDNA
CareDx Inc
63% Upside
VYGR
Voyager Therapeutics Inc
132% Upside
S
SABS
SAB Biotherapeutics Inc
328% Upside
M
MLYS
Mineralys Therapeutics Inc
182% Upside
688319
Chengdu Olymvax Biopharmaceuticals Inc
169% Upside
SPRY
ARS Pharmaceuticals Inc
123% Upside

Revenue
Forecast

Revenue Estimate
ABL Bio Inc

For the last 5 years the compound annual growth rate for ABL Bio Inc's revenue is 293%. The projected CAGR for the next 3 years is -25%.

293%
Past Growth
-25%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
ABL Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
ABL Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABL Bio Inc's stock price target?
Price Target
36 210 KRW

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 36 210 KRW with a low forecast of 35 350 KRW and a high forecast of 37 800 KRW.

What is ABL Bio Inc's Revenue forecast?
Projected CAGR
-25%

For the last 5 years the compound annual growth rate for ABL Bio Inc's revenue is 293%. The projected CAGR for the next 3 years is -25%.

ALPHA SPREAD
Join more than 133,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.